Compounds > gw420867x
Page last updated: 2024-09-04

gw420867x and 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil

gw420867x has been researched along with 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil in 1 studies

Compound Research Comparison

Studies
(gw420867x)		Trials
(gw420867x)		Recent Studies (post-2010)
(gw420867x)		Studies
(5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil)		Trials
(5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil)		Recent Studies (post-2010) (5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil)
17521301

Protein Interaction Comparison

ProteinTaxonomygw420867x (IC50)5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (IC50)
Reverse transcriptase/RNaseH Human immunodeficiency virus 10.032

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jorgensen, WL; Kroeger Smith, MB; Rizzo, RC; Smith, RH; Tirado-Rives, J; Udier-Blagović, M; Wang, DP; Watkins, EK1

Other Studies

1 other study(ies) available for gw420867x and 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil

ArticleYear
Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulations.
    Journal of medicinal chemistry, 2002, Jul-04, Volume: 45, Issue:14

    Topics: Alkynes; Anilides; Benzoxazines; Computer Simulation; Cyclopropanes; HIV Reverse Transcriptase; Hydrogen Bonding; Models, Molecular; Monte Carlo Method; Nevirapine; Oxazines; Protein Binding; Quinoxalines; Regression Analysis; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Uracil

2002